Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Maple Finance (SYRUP) Price & Performance

InjectiveTrade
Maple FinanceTrade

Price performance (Past 24H)

Key statistics

Injective vs Maple Finance — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume), while Maple Finance trades at Rp3,598 (market cap Rp4,26T, Rp333,6M 24h volume). The key difference: Injective is far larger — about 2.2× Maple Finance's market cap, and Injective's circulating supply is 100M INJ versus 1,2B SYRUP for Maple Finance. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Maple Finance for 13 Days on average.

INJSYRUP
Market Cap
Rp9,29TRp4,26T
Volume (24h)
Rp1,78TRp333,6M
Circulating Supply
100M INJ1,2B SYRUP
Typical Hold Time
36 Days13 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Maple Finance

Maple Finance (SYRUP) trades at Rp3,445 with a market cap of Rp4.1T, showing a bullish technical signal supported by moving averages. Key indicators include RSI_12 at 78.73 (sell signal) and ADX above 45 indicating a strong trend. Support lies at Rp3,290 and resistance at Rp3,594. No major protocol updates or ecosystem news were found recently.

Overall outlook is cautiously optimistic due to strong trend signals, but overbought RSI suggests near-term pullback risk. Opportunities include potential breakout above resistance; major risks involve high volatility and lack of recent fundamental catalysts. Investors should monitor volume and key levels closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
SYRUP
43% Buy57% Sell
Avg holding period · 13 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Maple Finance

Maple, launched in 2021, is an on-chain asset manager that combines decades of experience in traditional finance and cryptocurrency. By merging capital markets expertise with DeFi innovation, Maple offers a variety of products, including secured lending, Bitcoin yield strategies, and structured financial instruments.

Read more on SYRUP